COVID-19: How R&D Responded & What We Learned for Future Outbreaks

COVID-19: How R&D Responded & What We Learned for Future Outbreaks

In this Intelligence Brief, we take a deep dive into SARS-CoV-2 virus genetics and the strategies and tools that fueled the identification of new therapies. We also look into some of the latest research and treatments being developed.

Please enter your contact details to proceed.

First Name*

Last Name*

Business Email*

Company*


If you do not have access to your business email, please email us at info@prescouter.com for a copy of this report.

COVID-19: How R&D Responded & What We Learned for Future Outbreaks

As there is no approved treatment for COVID-19, the current standard of treatment has been to manage symptoms. Several existing and new therapies are being investigated for the treatment and prevention of COVID-19. In this Intelligence Brief, we showcase 35 and highlight 2.

Included in this Intelligence Brief:

  • The latest research developments in the following areas:
    • Bioinformatics & genomics
    • Characterizing the virus
    • Vaccine development
    • Cure development
    • Drug development
  • The possibility of new opportunities involving artificial intelligence

This Intelligence Brief is Part II of our 2-part series covering the COVID-19 pandemic. Part I on the epidemiology and current standard of care can be viewed here.

If you have any questions or would like to know if we can help your business with its innovation challenges, please contact us here or email us at solutions@prescouter.com.

Never miss an insight

Get insights delivered right to your inbox

More of Our Insights & Work

Never miss an insight

Get insights delivered right to your inbox

You have successfully subscribed to our newsletter.

Too many subscribe attempts for this email address.

*